Inventor · disambiguated record
Xiao Ding
Also filed as: DING XIAO · DING XIAO CHENG
20 granted patents·25 pending applications·18 citations·filing 2002–2025
91Inventor score
Files withINSILICO MEDICINE IP LTD21GLAXOSMITHKLINE IP DEV LTD6HOFFMANN LA ROCHE6SIGMA ALDRICH CO LLC3BEIGENE SWITZERLAND GMBH1
Top patents by PatentIndex Score
45 records- 0192US11731987B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 22, 2023·3 cites·30 claims
- 0291US10604752B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2018·Granted Mar 31, 2020·6 cites·22 claims
- 0390US11780854B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Oct 10, 2023·1 cites·29 claims
- 0486US11731944B2SARS-CoV-2 inhibitors for treating coronavirus infectionsINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 22, 2023·1 cites·27 claims
- 0581US12209101B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Jan 28, 2025·0 cites·14 claims
- 0681US12071443B2Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Aug 27, 2024·0 cites·21 claims
- 0781US12065642B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted Aug 20, 2024·1 cites·20 claims
- 0878US2025034132A1Prolyl hydroxylase domain-containing protein (phd) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 0977US9815841B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Nov 14, 2017·2 cites·13 claims
- 1073US11999713B2Methionine adenosyltransferase 2a (MAT2A) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Jun 4, 2024·0 cites·20 claims
- 1172US10618901B2LRRK2 inhibitors for the treatment of Parkinson's diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Apr 14, 2020·1 cites·21 claims
- 1272US2024025860A1Sars-cov-2 inhibitors for treating coronavirus infectionsINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1371US12077538B2Diacylglycerol kinase (DGK) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 1468US2024051958A1Diacylglycerol kinase (dgk) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1567US10975081B2Substituted fused pyrazole compounds and their use as LRRK2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 13, 2021·1 cites·18 claims
- 1667US10087186B2Compounds as LRRK2 kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 2, 2018·1 cites·15 claims
- 1766US12221606B2Using nucleosome interacting protein domains to enhance targeted genome modificationSIGMA ALDRICH CO LLC·Filed 2020·Granted Feb 11, 2025·0 cites·13 claims
- 1865US2025042890A1METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOFINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 1964US12103915B2TEAD inhibitors and methods of uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Oct 1, 2024·0 cites·26 claims
- 2064US2025340569A1Inhibitors of kif18a and uses thereofINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 2163US2025188094A1Pyrazole membrane-associated tyrosine-and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 2263US2025163077A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 2363US2025197405A1Heteroaromatic compounds as pkmyt1 inhibitors and use thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 2462US2025145624A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 2562US2025382297A1Inhibitors of fgfr2 and fgfr3 and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 2661US2025145632A1Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in MedicineINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 2760US11612811B2Game server switching method, apparatus, and systemTENCENT TECH SHENZHEN COMPANY LTD·Filed 2021·Granted Mar 28, 2023·0 cites·19 claims
- 2860US2025214967A1Fak degraders, pharmaceutical compositions, and therapeutic applicationsBERRYBIO SHANGHAI LTD·Filed 2023·Application pending·0 cites
- 2960US2025136596A1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (pkmyt1) inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3059US2025011300A1Piperazinylsulfonylaryl compounds for treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3159US2025107063A1Forming Connect Structures in Memory SystemsYANGTZE MEMORY TECH CO LTD·Filed 2023·Application pending·0 cites
- 3258US2025326842A1Anti-pvrig antibodies and methods of useBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 3357US2025214990A1Diacylglycerol kinase (dgk) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 3457US2024417387A1Sulfonylpiperazinyl compounds for treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3555US2023345936A1Novel environment-friendly herbicideKUNMING INST BOTANY CAS·Filed 2022·Application pending·0 cites
- 3655US2021221832A1Substituted pyridoindoles for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3754US11110347B2Game server switching method, apparatus, and systemTENCENT TECH SHENZHEN CO LTD·Filed 2019·Granted Sep 7, 2021·0 cites·20 claims
- 3854US2021317141A1Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3953US2021323981A1Free amino compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4051US2021238197A1Novel oxoquinolizine compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4145US2014249101A1Methods for treating hepatitis c virus infectionGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 4243US8001207B2Common location-based service adapter interface for location based servicesIBM·Filed 2002·Granted Aug 16, 2011·1 cites·1 claims
- 4342US12185521B2Method for manufacturing memory device and memoryICLEAGUE TECH CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 4439US10858367B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 8, 2020·0 cites·18 claims
- 4539US2020392158A1Inhibitors of leucine rich repeat kinase 2GLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiao Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →